Trials / Not Yet Recruiting
Not Yet RecruitingNCT07278362
Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
Safety of Intramuscular Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
- Status
- Not Yet Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 35 (estimated)
- Sponsor
- University of Miami · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is evaluate the safety of testosterone replacement therapy in men with newly diagnosed low-risk prostate cancer and hypogonadism on active surveillance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Testosterone cypionate | Participants will self-inject 100mg of testosterone cypionate once per week for 12 months |
Timeline
- Start date
- 2026-05-31
- Primary completion
- 2031-05-31
- Completion
- 2032-05-31
- First posted
- 2025-12-12
- Last updated
- 2026-02-23
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07278362. Inclusion in this directory is not an endorsement.